University of Pristina   Report issue

Academic/Hospital Phase 4
Founded: Pristina Kosovo (1969)

Organization Overview

First Clinical Trial
2019
NCT03921567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Eye Hospital Pristina Kosovo | University of Pristina, Faculty of Medicine, 10000 Pristina, Kosovo

Active Ingredients

Drugs in Phase 4 Trials (2)

ketamine (ketalar) (1 trial)

lidocaine (xylocaine) (1 trial)

Drugs in Other Trials (2)

autologous serum (1 trial)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Substance-Related Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4